News | August 20, 2014

Boston Scientific, Asahi Intecc Announce Joint Development, Manufacturing Programs

August 20, 2014 — Boston Scientific Corp. and Asahi Intecc have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. The joint project focuses on creating a device intended to improve handling compared to existing FFR wires.

The FFR market is an emerging field in interventional cardiology that exceeds $250 million worldwide and is experiencing a double-digit growth rate. FFR-guided percutaneous coronary intervention (PCI) is cost-effective and also reduces one-year major adverse cardiac events (MACE) rates. The jointly developed FFR wire will be designed for use with the Boston Scientific Polaris multimodality imaging system.

The companies have also agreed to collaborate on key enhancements to the Boston Scientific RotaWire atherectomy guidewire. Asahi Intecc will provide components for the new RotaWire, which is designed by Boston Scientific to provide improved control and handling. The RotaWire is a unique 0.009-inch wire that is used within the Rotablator rotational atherectomy system to treat calcified lesions in coronary arteries.

The introduction of the components manufactured by Asahi Intecc to advance the RotaWire atherectomy guidewire is further evidence of the Boston Scientific commitment to improving products used in the treatment of complex coronary disease.

"We expect our collaboration with Asahi Intecc to help improve care for patients with coronary artery disease and strengthen our interventional cardiology portfolio," said Kevin Ballinger, president, Interventional Cardiology, Boston Scientific. "The Asahi Intecc expertise in guidewire technology is unparalleled. By leveraging the strengths of our technologies, we have the opportunity to create truly differentiated products."

"Boston Scientific has advanced sensor and atherectomy technologies. By combining these technologies with our expertise in wires and components, we believe the manipulability of these products will improve dramatically," said Masahiko Miyata, president and CEO, Asahi Intecc. "Through our collaboration with Boston Scientific, we are confident that we will be able to help improve outcomes for patients."

Asahi Intecc specializes in wire drawing, wire forming, torque transmission and coating processes for percutaneous transluminal coronary angiography (PTCA) guidewires.

Boston Scientific anticipates commercializing both specialty wires in 2015.

For more information: www.bostonscientific.com

Related Content

Edwards Lifesciences Recalls Swan-Ganz hemodynamic catheters.
Feature | Cath Lab | February 06, 2019
Edwards Lifesciences is recalling its 131F7, 131F7J, 131F7P, 131VF7P, 151F7 Swan-Ganz Thermodilution Catheters manufa
Scientists Discover New Heart Attack Repair Pathway

A macrophage immune cell, with a dead cell (pink) that has been eaten, and a mitochondrion (green) between the dead cell and the nucleus. The study’s findings indicate that what the macrophage eats is taken up by the mitochondrion, which in turn communicates with the nucleus to activate the macrophage to promote tissue repair. Image courtesy of Northwestern Medicine.

News | Cath Lab | January 30, 2019
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing after a heart attack....
Shockwave Initiates U.S. Pivotal Study for Coronary Intravascular Lithotripsy
News | Cath Lab | January 16, 2019
Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE...
National Academy of Engineering, Ohio University Award 2019 Russ Prize
News | Cath Lab | January 03, 2019
Ohio University and the National Academy of Engineering announced the 2019 Fritz J. and Dolores H. Russ Prize will be...
Videos | Cath Lab | January 03, 2019
This is a walk through inside one of the cardiac hybrid cath labs at the...
Videos | Cath Lab | January 03, 2019
This is the newest cardiac cath lab at the ...
Study Finds Effective Treatment for Coronary Slow Flow
News | Cath Lab | December 27, 2018
Patients who arrive at the hospital with heart-attack-like symptoms have had little recourse for their chest pain if...
Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018
Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As outlined by the agreement...
Overlay Init